BCRX
BioCryst Pharmaceuticals Inc
NASDAQ: BCRX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$8.99
+1.47% today
Updated 2026-04-29
Market cap
$2.28B
P/E ratio
7.43
P/S ratio
2.61x
EPS (TTM)
$1.21
Dividend yield
—
52W range
$6 – $11
Volume
5.5M
BioCryst Pharmaceuticals Inc (BCRX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-15.21M | $-25.00M | $-20.87M | $-16.22M | $-28.55M | $-32.25M | $-37.40M | $-26.53M | $-38.55M | $-13.12M | $-53.44M | $-41.14M | $-92.56M | $-89.58M | $-137.22M | $-142.16M | $-161.85M | $-95.14M | $-52.02M | $329.88M |
| Capital expenditures | $1.53M | $3.34B | $1.21M | $603692.00 | $324764.00 | $55000.00 | $113000.00 | $30000.00 | $106000.00 | $5.12M | $5.28M | $328000.00 | $366000.00 | $343000.00 | $514000.00 | $2.38M | $1.35M | $2.17M | $1.12M | $2.47M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $3.34B | $5.69B | $5.86B | $5.52M | $6.30M | $4.77M | $4.17M | $4.37M | $10.18M | $9.71M | $8.49M | $12.62M | $9.40M | $17.72M | $14.79M | $34.64M | $44.70M | $55.62M | $65.41M | $85.07M |
| Free cash flow | $-16.75M | $-3.37B | $-22.09M | $-16.82M | $-28.88M | $-32.31M | $-37.51M | $-26.56M | $-38.66M | $-18.24M | $-58.72M | $-41.47M | $-92.93M | $-89.93M | $-137.73M | $-144.54M | $-163.20M | $-97.31M | $-53.14M | $327.41M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $2.82M | $4.45M | $273000.00 | $33.38M | $-25.64M | $-6.79M | $28.18M | $-25.29M | $87.45M | $158.63M | $233.39M | — | — | — | — |